By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Advances in Thyroid Care
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > News > Advances in Thyroid Care
NewsWellness

Advances in Thyroid Care

Annie Qureshi
Annie Qureshi
Share
4 Min Read
SHARE

Roughly 57,000 people are diagnosed with thyroid cancer every year in the U.S. alone. Those who are able to catch the disease in its early stages have extremely high chances of making a full recovery when they have the thyroid surgically removed. However, there are nearly 100,000 people annually who actually end up having their thyroid removed when it wasn?t really necessary to do so. For those individuals, the surgery, as well as its associated costs and emotional effects, could have been avoided. That?s why experts have been working hard to create advancements in the realm of thyroid care, and at this year?s American Thyroid Association?s Annual Meeting, a new diagnostic tool was introduced that has the potential to eliminate unnecessary thyroid removals.

Contents
  • A Bit of Background on ThyroSeq V3
  • Doctors on Board for Changes
  • Excitement Over ThyroSeq V3

A Bit of Background on ThyroSeq V3

For the last 10 years, ThyroSeq has been combining the biggest scientific discoveries and advanced technology in an effort to help medical professionals give the most accurate diagnoses of malignant and benign nodules in the thyroid. One of the biggest advancements in thyroid care recently came with the study on ThyroSeq V3. ThyroSeq is a partnership between CBLPath and UPMC, and the results of this study were presented at the 87th Annual Meeting of the American Thyroid Association. The study was a multi-center, double-blind international study that was able to validate the latest version of ThyroSeq and its ability to more accurately diagnose cancer when there are nodules on the thyroid. The goal of ThyroSeq is to reduce the number of unnecessary diagnostic thyroid surgeries and to improve the ability of medical professionals to diagnose patients. And the study proves its success. ?Every indication is that we?ll be able to avoid countless unnecessary thyroid surgeries and offer more effective, individualized management of patients with thyroid nodules and cancer, based on this utting-edge genomic science,” said Yuri Nikiforov, M.D., Ph.D, Professor of Pathology at University of Pittsburgh Medical Center, and principal investigator of the multi-center ThyroSeq V3 trial.

Doctors on Board for Changes

Recently, thyroid experts have voiced their concerns regarding the many thyroid surgeries that are performed every year. They feel that one of the ways to start shifting the methods used to diagnose thyroid cancer would be to remove the term ?carcinoma? from one of the more common types of thyroid cancer because it actually isn?t invasive to other tissues and shouldn?t be considered cancer anymore. The hope is that, once the word cancer is removed from the name, surgery and radio iodine treatments that are ultimately unnecessary could be avoided. But whether or not the name is changed, better diagnostic procedures that make use of advanced technology are needed in order to reduce the number of unnecessary thyroid surgeries in the U.S.

Excitement Over ThyroSeq V3

After ThyroSeq?s study results were presented, experts became excited at the idea of being able to use ThyroSeq V3 in standard clinical settings as a trusted diagnostic method. Doctors now have a great tool that can be used across demographics and on benign and malignant nodules. That?s because V3 features a larger genomic classifier, which exhibits greater sensitivity and specificity when it comes to thyroid cancer detection. Overall, ThyroSeq V3 offers a procedure that could help to reduce both exploratory and diagnostic surgeries by as much as 60% amongst individuals who have thyroid nodules. It won?t be long before it becomes the standard of care in the treatment of these thyroid problems.

More Read

physician care
High Reliability Boot Camp: Preparing for Zero Preventable Harm
How Bad Breathing Habits Can Affect Your Health
5 Medical Risks That Pregnant Women Need to Be Aware Of
How the Pandemic Changed the Daily Role of Medical Office Assistants
Demystifying Medicare: Understanding Coverage and Eligibility
TAGGED:ThyroidThyroSeq
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Home HealthWellness

Stop The Sneeze: 10 Helpful Tips On How To Deal With Allergies

October 10, 2018
Wellness

7 Tips to Reduce the Risks of Bone Fractures

April 19, 2018
Home HealthWellness

How To Prevent Indoor Air Pollution When Working From Home

June 26, 2020

How I fell in love at TEDMED

April 16, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?